View Item 

Show simple item record

A comprehensive geneâ environment interaction analysis in Ovarian Cancer using genomeâ wide significant common variants
dc.contributor.authorKim, Sehee
dc.contributor.authorWang, Miao
dc.contributor.authorTyrer, Jonathan P.
dc.contributor.authorJensen, Allan
dc.contributor.authorWiensch, Ashley
dc.contributor.authorLiu, Gang
dc.contributor.authorLee, Alice W.
dc.contributor.authorNess, Roberta B.
dc.contributor.authorSalvatore, Maxwell
dc.contributor.authorTworoger, Shelley S.
dc.contributor.authorWhittemore, Alice S.
dc.contributor.authorAnton‐culver, Hoda
dc.contributor.authorSieh, Weiva
dc.contributor.authorOlson, Sara H.
dc.contributor.authorBerchuck, Andrew
dc.contributor.authorGoode, Ellen L.
dc.contributor.authorGoodman, Marc T.
dc.contributor.authorDoherty, Jennifer Anne
dc.contributor.authorChenevix‐trench, Georgia
dc.contributor.authorRossing, Mary Anne
dc.contributor.authorWebb, Penelope M.
dc.contributor.authorGiles, Graham G.
dc.contributor.authorTerry, Kathryn L.
dc.contributor.authorZiogas, Argyrios
dc.contributor.authorFortner, Renée T.
dc.contributor.authorMenon, Usha
dc.contributor.authorGayther, Simon A.
dc.contributor.authorWu, Anna H.
dc.contributor.authorSong, Honglin
dc.contributor.authorBrooks‐wilson, Angela
dc.contributor.authorBandera, Elisa V.
dc.contributor.authorCook, Linda S.
dc.contributor.authorCramer, Daniel W.
dc.contributor.authorMilne, Roger L.
dc.contributor.authorWinham, Stacey J.
dc.contributor.authorKjaer, Susanne K.
dc.contributor.authorModugno, Francesmary
dc.contributor.authorThompson, Pamela J.
dc.contributor.authorChang‐claude, Jenny
dc.contributor.authorHarris, Holly R.
dc.contributor.authorSchildkraut, Joellen M.
dc.contributor.authorLe, Nhu D.
dc.contributor.authorWentzensen, Nico
dc.contributor.authorTrabert, Britton
dc.contributor.authorHøgdall, Estrid
dc.contributor.authorHuntsman, David
dc.contributor.authorPike, Malcolm C.
dc.contributor.authorPharoah, Paul D.P.
dc.contributor.authorPearce, Celeste Leigh
dc.contributor.authorMukherjee, Bhramar
dc.date.accessioned2019-03-11T15:35:07Z
dc.date.available2020-07-01T17:47:46Zen
dc.date.issued2019-05-01
dc.identifier.citationKim, Sehee; Wang, Miao; Tyrer, Jonathan P.; Jensen, Allan; Wiensch, Ashley; Liu, Gang; Lee, Alice W.; Ness, Roberta B.; Salvatore, Maxwell; Tworoger, Shelley S.; Whittemore, Alice S.; Anton‐culver, Hoda ; Sieh, Weiva; Olson, Sara H.; Berchuck, Andrew; Goode, Ellen L.; Goodman, Marc T.; Doherty, Jennifer Anne; Chenevix‐trench, Georgia ; Rossing, Mary Anne; Webb, Penelope M.; Giles, Graham G.; Terry, Kathryn L.; Ziogas, Argyrios; Fortner, Renée T. ; Menon, Usha; Gayther, Simon A.; Wu, Anna H.; Song, Honglin; Brooks‐wilson, Angela ; Bandera, Elisa V.; Cook, Linda S.; Cramer, Daniel W.; Milne, Roger L.; Winham, Stacey J.; Kjaer, Susanne K.; Modugno, Francesmary; Thompson, Pamela J.; Chang‐claude, Jenny ; Harris, Holly R.; Schildkraut, Joellen M.; Le, Nhu D.; Wentzensen, Nico; Trabert, Britton; Høgdall, Estrid ; Huntsman, David; Pike, Malcolm C.; Pharoah, Paul D.P.; Pearce, Celeste Leigh; Mukherjee, Bhramar (2019). "A comprehensive geneâ environment interaction analysis in Ovarian Cancer using genomeâ wide significant common variants." International Journal of Cancer 144(9): 2192-2205.
dc.identifier.issn0020-7136
dc.identifier.issn1097-0215
dc.identifier.urihttps://hdl.handle.net/2027.42/148230
dc.publisherJohn Wiley & Sons, Inc.
dc.subject.otherovarian cancer
dc.subject.otherG Ã E
dc.subject.otheradditive interaction
dc.subject.othergenetics
dc.titleA comprehensive geneâ environment interaction analysis in Ovarian Cancer using genomeâ wide significant common variants
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/148230/1/ijc32029.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/148230/2/ijc32029_am.pdf
dc.identifier.doi10.1002/ijc.32029
dc.identifier.sourceInternational Journal of Cancer
dc.identifier.citedreferencePearce CL, Templeman C, Rossing MA, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of caseâ control studies. Lancet Oncol 2012; 13: 385 â 94.
dc.identifier.citedreferenceSociety AC. Cancer Facts & Figures 2017. American Cancer Society 2017.
dc.identifier.citedreferenceJacobs IJ, Menon U, Ryan A, et al. Ovarian cancer screening and mortality in the UK collaborative trial of Ovarian Cancer screening (UKCTOCS): a randomised controlled trial. Lancet (London, England) 2016; 387: 945 â 56.
dc.identifier.citedreferencePearce CL, Rossing MA, Lee AW, et al. Combined and interactive effects of environmental and GWASâ identified risk factors in ovarian cancer. Cancer Epidemiol Biomarkers Prev 2013; 22: 880 â 90.
dc.identifier.citedreferenceTrabert B, Ness RB, Loâ Ciganic WH, et al. Aspirin, nonaspirin nonsteroidal antiâ inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer association consortium. J Natl Cancer Inst 2014; 106: djt431.
dc.identifier.citedreferenceSieh W, Salvador S, McGuire V, et al. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of caseâ control studies. Int J Epidemiol 2013; 42: 579 â 89.
dc.identifier.citedreferenceFalconer H, Yin L, Gronberg H, et al. Ovarian cancer risk after salpingectomy: a nationwide populationâ based study. J Natl Cancer Inst 2015; 107: dju410.
dc.identifier.citedreferenceLessardâ Anderson CR, Handlogten KS, Molitor RJ, et al. Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma. Gynecol Oncol 2014; 135: 423 â 7.
dc.identifier.citedreferenceMadsen C, Baandrup L, Dehlendorff C, et al. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide caseâ control study. Acta Obstet Gynecol Scand 2015; 94: 86 â 94.
dc.identifier.citedreferenceYoon SH, Kim SN, Shim SH, et al. Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a metaâ analysis. Eur J Cancer 2016; 55: 38 â 46.
dc.identifier.citedreferenceBojesen SE, Pooley KA, Johnatty SE, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013; 45: 371 â 84. 84e1â 2.
dc.identifier.citedreferenceBolton KL, Tyrer J, Song H, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2010; 42: 880 â 4.
dc.identifier.citedreferenceGoode EL, Chenevixâ Trench G, Song H, et al. A genomeâ wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 2010; 42: 874 â 9.
dc.identifier.citedreferenceKar SP, Beesley J, Amin Al Olama A, et al. Genomeâ wide metaâ analyses of breast, Ovarian, and prostate Cancer association studies identify multiple new susceptibility loci shared by at least two Cancer types. Cancer Discov 2016; 6: 1052 â 67.
dc.identifier.citedreferenceKelemen LE, Lawrenson K, Tyrer J, et al. Genomeâ wide significant risk associations for mucinous ovarian carcinoma. Nat Genet 2015; 47: 888 â 97.
dc.identifier.citedreferenceKuchenbaecker KB, Ramus SJ, Tyrer J, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat Genet 2015; 47: 164 â 71.
dc.identifier.citedreferencePermuthâ Wey J, Lawrenson K, Shen HC, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature communications 2013; 4: 1627.
dc.identifier.citedreferencePharoah PD, Tsai YY, Ramus SJ, et al. GWAS metaâ analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 2013; 45: 362 â 70. 70e1â 2.
dc.identifier.citedreferencePhelan CM, Kuchenbaecker KB, Tyrer JP, et al. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat Genet 2017; 49: 680 â 91.
dc.identifier.citedreferenceShen H, Fridley BL, Song H, et al. Epigenetic analysis leads to identification of HNF1B as a subtypeâ specific susceptibility gene for ovarian cancer. Nat Commun 2013; 4: 1628.
dc.identifier.citedreferenceSong H, Ramus SJ, Tyrer J, et al. A genomeâ wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009; 41: 996 â 1000.
dc.identifier.citedreferenceAuranen A, Pukkala E, Makinen J, et al. Cancer incidence in the firstâ degree relatives of ovarian cancer patients. Duodecim; laaketieteellinen aikakauskirja 1997; 113: 46 â 50.
dc.identifier.citedreferenceStratton JF, Pharoah P, Smith SK, et al. A systematic review and metaâ analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol 1998; 105: 493 â 9.
dc.identifier.citedreferenceLee AW, Ness RB, Roman LD, et al. Association between menopausal estrogenâ only therapy and Ovarian carcinoma risk. Obstet Gynecol 2016; 127: 828 â 36.
dc.identifier.citedreferencePearce CL, Chung K, Pike MC, et al. Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin. Cancer 2009; 115: 531 â 9.
dc.identifier.citedreferenceCollaborative Group On Epidemiological Studies Of Ovarian C, Beral V, Gaitskell K, et al. Menopausal hormone use and ovarian cancer risk: individual participant metaâ analysis of 52 epidemiological studies. Lancet (London, England) 2015; 385: 1835 â 42.
dc.identifier.citedreferenceOlsen CM, Nagle CM, Whiteman DC, et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer association consortium. Endocr Relat Cancer 2013; 20: 251 â 62.
dc.identifier.citedreferenceSEER Cancer Statistics Review 1975 â 2014, Based on November 2016 SEER data submission, posted to the SEER web site, April 2017.
dc.identifier.citedreferencePearce CL, Stram DO, Ness RB, et al. Population distribution of lifetime risk of Ovarian Cancer in the United States. Cancer Epidemiol Biomarkers Prev 2015; 24: 671 â 6.
dc.identifier.citedreferenceLiu G, Lee S, Lee AW, et al. Robust tests for additive geneâ environment interaction in caseâ control studies using geneâ environment Independence. Am J Epidemiol 2017; 187: 366 â 377.
dc.identifier.citedreferenceGarciaâ Closas M, Rothman N, Figueroa JD, et al. Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res 2013; 73: 2211 â 20.
dc.identifier.citedreferenceKnol MJ, Vanderweele TJ, Groenwold RH, et al. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol 2011; 26: 433 â 8.
dc.identifier.citedreferenceLiu G, Mukherjee B, Lee S, et al. Robust tests for additive geneâ environment interaction in caseâ control studies using geneâ environment Independence. Am J Epidemiol 2018; 187: 366 â 77.
dc.identifier.citedreferenceVanderweele TJ, Vansteelandt S. A weighting approach to causal effects and additive interaction in caseâ control studies: marginal structural linear odds models. Am J Epidemiol 2011; 174: 1197 â 203.
dc.identifier.citedreferenceVanderweele TJ. Sample size and power calculations for additive interactions. Epidemiol Methods 2012; 1: 159 â 88.
dc.identifier.citedreferenceBolton KL, Ganda C, Berchuck A, et al. Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer association consortium (OCAC). J Intern Med 2012; 271: 366 â 78.
dc.identifier.citedreferenceLittle RJA, Rubin DB. Chapter 10: Bayes and multiple imputation statistical analysis with missing data, 2nd edn. NJ: John Wiley & Sons, 2002.
dc.identifier.citedreferenceNickels S, Truong T, Hein R, et al. Evidence of geneâ environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet 2013; 9: e1003284.
dc.identifier.citedreferenceBhattacharjee S Cn, Han S and Wheeler W. CGEN: An R package for analysis of caseâ control studies in genetic epidemiology, 2012.
dc.identifier.citedreferenceHan SS, Rosenberg PS, Garciaâ Closas M, et al. Likelihood ratio test for detecting gene (G)â environment (E) interactions under an additive risk model exploiting Gâ E independence for caseâ control data. Am J Epidemiol 2012; 176: 1060 â 7.
dc.identifier.citedreferenceSEER, ed. Cancer stat facts: Ovarian Cancer. In: SEER, ed., vol. 2017. National Cancer Institute. Bethesda, MD.
dc.identifier.citedreferenceHaiman CA, Patterson N, Freedman ML, et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 2007; 39: 638 â 44.
dc.identifier.citedreferenceShi J, Zhang Y, Zheng W, et al. Fineâ scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. Int J Cancer 2016; 139: 1303 â 17.
dc.identifier.citedreferenceTseng YY, Bagchi A. The PVT1â MYC duet in cancer. Mol Cell Oncol 2015; 2: e974467.
dc.identifier.citedreferenceShang Y, Brown M. Molecular determinants for the tissue specificity of SERMs. Science 2002; 295: 2465 â 8.
dc.identifier.citedreferenceWang C, Mayer JA, Mazumdar A, et al. Estrogen induces câ myc gene expression via an upstream enhancer activated by the estrogen receptor and the APâ 1 transcription factor. Mol Endocrinol 2011; 25: 1527 â 38.
dc.identifier.citedreferenceLee AW, Bomkamp A, Bandera EV, et al. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. Int J Cancer 2016; 139: 2646 â 54.
dc.identifier.citedreferenceUsset JL, Raghavan R, Tyrer JP, et al. Assessment of multifactor geneâ environment interactions and Ovarian Cancer risk: candidate genes, obesity, and hormoneâ related risk factors. Cancer Epidemiol Biomarkers Prev 2016; 25: 780 â 90.
dc.identifier.citedreferenceDimitrakopoulou VI, Travis RC, Shui IM, et al. Interactions between genomeâ wide significant genetic variants and circulating concentrations of 25â Hydroxyvitamin D in relation to prostate Cancer risk in the National Cancer Institute BPC3. Am J Epidemiol 2017; 185: 452 â 64.
dc.identifier.citedreferenceMcAllister K, Mechanic LE, Amos C, et al. Current challenges and new opportunities for geneâ environment interaction studies of complex diseases. Am J Epidemiol 2017; 186: 753 â 61.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ijc32029.pdf
Size:
733.0KB
Format:
PDF
View/Open
Name:
ijc32029_am.pdf
Size:
306.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.